Researchers have developed a novel technique that inserts a gene encoding lymphoma mutation into normal human T cells, making them more than 100 times more potent at killing cancer cells. The study of naturally occurring mutations in T cell cancers has identified a gene fusion that boosts the efficacy of therapeutic T cells. Additionally, a new Cleveland Clinic breast cancer vaccine is showing promising results in trial patients. Lung cancer cells have been found to change their driver gene mutations and identity to escape attack.
This was just a great discussion with the amazing Nina Bhardwaj, MD, PhD @BhardwajLab @MountSinaiNYC Part of @parkerici's “From Bench to Fireside”. Dr. Bhardwaj’s talks about her incredible research and the potential of cancer vaccines moving forward. https://t.co/dMK779ZfUq
A study of naturally occurring mutations in T cell cancers identifies a gene fusion that boosts the efficacy of therapeutic T cells. #NBThighlight https://t.co/jvT088I6Eh
Scientists at UCSF and Northwestern Medicine have developed a new technique that makes T cells 100 times more potent at killing cancer cells without any signs of becoming toxic. Read more: https://t.co/v1XYs1J0or https://t.co/M1qBmO86U3
Lung cancer cells can function like "Catch Me If You Can," changing their driver gene mutations and identity to escape attack https://t.co/djjSw4jdqL https://t.co/CSMW4cOYZS @ScienceMagazine @ScienceVisuals https://t.co/OhD2nWFo4a
Doctors say cancer vaccines show promising results in trial patients A new Cleveland Clinic breast cancer vaccine is showing promising results in trial patients. NBC News' Natalie Azar explains how these vaccines can be a breakthrough to fight cancer. Source: NBC News (YouTube) https://t.co/gxQKRS8xR2
Great to discuss pandemics, prevention, and progress in public health with the @NFIDVaccines podcast, Infectious Ideas. Have a listen: https://t.co/vJbuqIt76p
Novel Technique Makes Cancer's Power Turn Against Itself A new method that inserts a gene encoding lymphoma mutation into normal human T cells made them more than 100 times more potent at killing cancer cells. Read more: https://t.co/mwgvLm9NG9 https://t.co/HQCr0ztIwz
Immune cells armed with a mutation first identified in cancer cells gain potency - but don’t turn cancerous themselves https://t.co/pvWAaALyfW
Latest from the Nature Podcast 🔊 Cancer’s power harnessed — lymphoma mutations supercharge T cells https://t.co/TfsDFIBihh